229 related articles for article (PubMed ID: 32486903)
21. Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.
Rodieux F; Gotta V; Pfister M; van den Anker JN
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S173-92. PubMed ID: 27385174
[TBL] [Abstract][Full Text] [Related]
22. Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective.
Umamaheswaran G; Kumar DK; Adithan C
Indian J Med Res; 2014 Jan; 139(1):27-65. PubMed ID: 24604039
[TBL] [Abstract][Full Text] [Related]
23. Profiling of Drug-Metabolizing Enzymes and Transporters in Human Tissue Biopsy Samples: A Review of the Literature.
Rodrigues AD; Rowland A
J Pharmacol Exp Ther; 2020 Mar; 372(3):308-319. PubMed ID: 31879375
[TBL] [Abstract][Full Text] [Related]
24. Deregulation of the Genes that Are Involved in Drug Absorption, Distribution, Metabolism, and Excretion in Hepatocellular Carcinoma.
Hu DG; Marri S; McKinnon RA; Mackenzie PI; Meech R
J Pharmacol Exp Ther; 2019 Mar; 368(3):363-381. PubMed ID: 30578287
[TBL] [Abstract][Full Text] [Related]
25. [The pharmacogenomics of drug transporters: functional analysis approaches].
Ishikawa T; Endou H; Inui K; Tsuji A; Wada M; Sumino Y
Tanpakushitsu Kakusan Koso; 2004 Sep; 49(12):2024-34. PubMed ID: 15449720
[No Abstract] [Full Text] [Related]
26. The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders.
Wu KC; Lin CJ
J Food Drug Anal; 2019 Jan; 27(1):48-59. PubMed ID: 30648594
[TBL] [Abstract][Full Text] [Related]
27. Pharmacogenomics of phase II metabolizing enzymes and drug transporters: clinical implications.
Yiannakopoulou ECh
Pharmacogenomics J; 2013 Apr; 13(2):105-9. PubMed ID: 23044602
[TBL] [Abstract][Full Text] [Related]
28. Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing.
Silgado-Guzmán DF; Angulo-Aguado M; Morel A; Niño-Orrego MJ; Ruiz-Torres DA; Contreras Bravo NC; Restrepo CM; Ortega-Recalde O; Fonseca-Mendoza DJ
Front Pharmacol; 2022; 13():931531. PubMed ID: 35846994
[TBL] [Abstract][Full Text] [Related]
29. Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians.
Sortica Vde A; Ojopi EB; Genro JP; Callegari-Jacques S; Ribeiro-Dos-Santos A; de Moraes MO; Romano-Silva MA; Pena SD; Suarez-Kurtz G; Hutz MH
Basic Clin Pharmacol Toxicol; 2012 May; 110(5):460-8. PubMed ID: 22136368
[TBL] [Abstract][Full Text] [Related]
30. The role of ADME pharmacogenomics in early clinical trials: perspective of the Industry Pharmacogenomics Working Group (I-PWG).
Tremaine L; Brian W; DelMonte T; Francke S; Groenen P; Johnson K; Li L; Pearson K; Marshall JC
Pharmacogenomics; 2015 Dec; 16(18):2055-67. PubMed ID: 26616152
[TBL] [Abstract][Full Text] [Related]
31. DMET™ (Drug-Metabolizing Enzymes and Transporters) microarray analysis of colorectal cancer patients with severe 5-fluorouracil-induced toxicity.
Rumiato E; Boldrin E; Amadori A; Saggioro D
Cancer Chemother Pharmacol; 2013 Aug; 72(2):483-8. PubMed ID: 23760813
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenomics, ancestry and clinical decision making for global populations.
Ramos E; Doumatey A; Elkahloun AG; Shriner D; Huang H; Chen G; Zhou J; McLeod H; Adeyemo A; Rotimi CN
Pharmacogenomics J; 2014 Jun; 14(3):217-22. PubMed ID: 23835662
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenetics of common SNP affecting drug metabolizing enzymes: comparison of allele frequencies between European and Malaysian/Singaporean.
Bakar NS
Drug Metab Pers Ther; 2021 Mar; ():. PubMed ID: 33735954
[TBL] [Abstract][Full Text] [Related]
34. Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium.
Evers R; Piquette-Miller M; Polli JW; Russel FGM; Sprowl JA; Tohyama K; Ware JA; de Wildt SN; Xie W; Brouwer KLR;
Clin Pharmacol Ther; 2018 Nov; 104(5):900-915. PubMed ID: 29756222
[TBL] [Abstract][Full Text] [Related]
35. Genetic structure of pharmacogenetic biomarkers in Brazil inferred from a systematic review and population-based cohorts: a RIBEF/EPIGEN-Brazil initiative.
Rodrigues-Soares F; Kehdy FSG; Sampaio-Coelho J; Andrade PXC; Céspedes-Garro C; Zolini C; Aquino MM; Barreto ML; Horta BL; Lima-Costa MF; Pereira AC; LLerena A; Tarazona-Santos E
Pharmacogenomics J; 2018 Dec; 18(6):749-759. PubMed ID: 29713005
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetics of drug transporters.
Franke RM; Gardner ER; Sparreboom A
Curr Pharm Des; 2010; 16(2):220-30. PubMed ID: 19835554
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.
Ahmed S; Zhou Z; Zhou J; Chen SQ
Genomics Proteomics Bioinformatics; 2016 Oct; 14(5):298-313. PubMed ID: 27729266
[TBL] [Abstract][Full Text] [Related]
38. Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder.
Medhasi S; Pasomsub E; Vanwong N; Ngamsamut N; Puangpetch A; Chamnanphon M; Hongkaew Y; Limsila P; Pinthong D; Sukasem C
Neuropsychiatr Dis Treat; 2016; 12():843-51. PubMed ID: 27110117
[TBL] [Abstract][Full Text] [Related]
39. The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology.
Nigam SK; Bush KT; Bhatnagar V; Poloyac SM; Momper JD
Clin Pharmacol Ther; 2020 Jul; 108(1):40-53. PubMed ID: 32119114
[TBL] [Abstract][Full Text] [Related]
40. Mannose-binding lectin and MBL-associated serine protease-2 gene polymorphisms in a Brazilian population from Rio de Janeiro.
Ferraroni NR; Segat L; Guimarães RL; Brandão LA; Crovella S; Constantino-Silva RN; Loja C; da Silva Duarte AJ; Grumach AS
Int J Immunogenet; 2012 Feb; 39(1):32-8. PubMed ID: 22035380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
